We need your help with two ground breaking initiatives: The National Cost of Illness study & the Australian Juvenile Arthritis Registry (AJAR)
In JAFA’s 9th Online Symposium on The Future of Paediatric Rheumatology, Dr Ben Whitehead and Dr Pavla Walsh talk about new and emerging medications and standards of care, and what to expect in pain management in the future. They are joined by Australia’s younger generation of paediatric rheumatologists who share their thoughts on the future of treatment and care of JIA and CRDs.
On March 21st 2023 in Parliament House Canberra, Assistant Health Minister, the Hon Ged Kearney launched the Australian Juvenile Arthritis Registry – another pivotal landmark in the history of juvenile arthritis in Australia.
The first-ever comprehensive national survey of the cost of juvenile arthritis and childhood rheumatic diseases in Australia is now open and we are asking for your participation.
This landmark national Cost of Illness Study will provide essential baseline information to address knowledge and evidence gaps about the financial impact of juvenile arthritis on the health system, on families and on the wider economy and will inform future national health policy and planning to improve services and support for juvenile arthritis. The study will cover 0-25yr olds.
When we recently had afternoon tea with the Prime Minister at the lodge in Canberra, we presented him with messages from some kids and young people with arthritis. They provided insights into living with these diseases, and they shared their thoughts on
What it’s like to have arthritis and What they would do for juvenile arthritis if they were Prime Minister.
On November 25, in response to a request from JAFA, the Prime Minister, Mr Anthony
JAFA’s 8th Online Symposium addressed the all-important topic of ensuring optimal and timely medical and home management of acute episodes and intercurrent illness that may arise unexpectedly in children with juvenile arthritis.
Thank you to Australian investment company Five V Capital and Adrian and Charlotte MacKenzie who
This is the new iteration of the influential House of Representatives Committee that conducted the
